AI In Oncology Market Report by Component (Software Solutions, Hardware, Services), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, and Others), Treatment Type (Chemotherapy, Radiotherapy, Immunotherapy, and Others), Application (Cancer Detection, Drug Discovery, Drug Development, and Others), and Region 2024-2032

AI In Oncology Market Report by Component (Software Solutions, Hardware, Services), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, and Others), Treatment Type (Chemotherapy, Radiotherapy, Immunotherapy, and Others), Application (Cancer Detection, Drug Discovery, Drug Development, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A12484
Buy Now

Market Overview:

The global AI In oncology market size reached US$ 1,172.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 13,871.7 Million by 2032, exhibiting a growth rate (CAGR) of 31.59% during 2024-2032. The escalating prevalence of cancer, rising awareness among the masses regarding early diagnosis of cancer, and the introduction of AI-based clinical decision support system represent some of the key factors driving the market.

Report Attribute
 Key Statistics 
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Size in 2023 US$ 1,172.5 Million
Market Forecast in 2032 US$ 13,871.7 Million
Market Growth Rate (2024-2032) 31.59%


Artificial intelligence (AI) in oncology refers to the use of algorithms and technology in cancer research and treatment. It has revolutionized the field of oncology by facilitating early detection of cancer, developing precision medicine, enabling drug discovery, and designing personalized treatment plans. AI in oncology is widely used to treat breast, ovarian, lung, prostate, colorectal, skin, leukaemia, and brain cancers. It aids in analyzing large volumes of data quickly, identifying patterns, improving treatment accuracy, and reducing the risk of misdiagnosis and delayed detection. AI in oncology can also inspect results from mammograms, computed tomography (CT) scans, and pathology slides to identify potentially cancerous lesions and assist radiologists and pathologists in making accurate diagnoses. It also provides data-driven insights into electronic health records, genomics data, and clinical trials, which aids in discovering new biomarkers and improving the understanding of cancer biology.

AI In Oncology Market Trends:

The escalating prevalence of cancer across the globe due to genetics and unhealthy lifestyle is one of the primary factors propelling the market growth. AI in oncology is widely used in chemotherapy, radiotherapy, immunotherapy, and other treatments to predict outcomes, optimize parameters, select the most suitable therapy option, and assist healthcare professionals in making informed decisions. In addition to this, the widespread technology utilization to predict the likelihood of disease progression, recurrence, and overall survival rate of patients is acting as another growth-inducing factor. Furthermore, the rising awareness among the masses regarding early detection and diagnosis of cancer to enable quick intervention and prevent future complications is providing an impetus to the market growth. Additionally, the introduction of AI-based clinical decision support systems, which aids oncologists in analyzing patient-specific data, such as clinical records, imaging data, and molecular profiles, to select appropriate therapies, predict treatment outcomes, and manage potential side effects, is positively influencing the market growth. Moreover, the acute shortages of healthcare professionals in the field of oncology are facilitating the demand for AI-based solutions to provide accurate and efficient treatment and diagnosis. Apart from this, the implementation of supportive government policies to spread awareness regarding cancers and their treatments and provide access to high-quality healthcare facilities is contributing to the market growth. Other factors, including the growing healthcare expenditure, increasing investment by government and private organizations in cancer research, and the rising demand for precision medicine, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global AI In oncology market report, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on component, cancer type, treatment type, and application.

Component Insights:

  • Software Solutions
  • Hardware
  • Services
     

The report has provided a detailed breakup and analysis of the AI In oncology market based on component. This includes software solutions, hardware, and services. According to the report, software solutions represented the largest segment.

Cancer Type Insights:

  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Brain Tumor
  • Others
     

A detailed breakup and analysis of the AI In oncology market based on the cancer type has also been provided in the report. This includes breast cancer, lung cancer, prostate cancer, colorectal cancer, brain tumor, and others. According to the report, breast cancer accounted for the largest market share.

Treatment Type Insights:

  • Chemotherapy
  • Radiotherapy
  • Immunotherapy
  • Others
     

A detailed breakup and analysis of the AI In oncology market based on the treatment type has also been provided in the report. This includes chemotherapy, radiotherapy, immunotherapy, and others. According to the report, chemotherapy accounted for the largest market share.

Application Insights:

  • Cancer Detection
  • Drug Discovery
  • Drug Development
  • Others
     

A detailed breakup and analysis of the AI In oncology market based on the application has also been provided in the report. This includes cancer detection, drug discovery, drug development, and others.

Regional Insights:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for AI In oncology. Some of the factors driving the North America AI in oncology market included growing incidences of cancer, supportive government policies, and significant technological advancements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global AI In oncology market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Azra AI, ConcertAI (SymphonyAI LLC), Digital Diagnostics Inc., MEDIAN Technologies, Medtronic plc, PathAI Inc., Siemens Healthineers GmbH (Siemens AG), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

AI In Oncology Market Report Scope:

Report Features Details
Base Year of the Analysis 2023
 Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: · 
  • Component
  • Cancer Type
  • Treatment Type
  • Application
  • Region
Components Covered Software Solutions, Hardware, Services
Cancer Types Covered Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others
Treatment Types Covered Chemotherapy, Radiotherapy, Immunotherapy, Others
Applications Covered Cancer Detection, Drug Discovery, Drug Development, Others
Regions Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Azra AI, ConcertAI (SymphonyAI LLC), Digital Diagnostics Inc., MEDIAN Technologies, Medtronic plc, PathAI Inc., Siemens Healthineers GmbH (Siemens AG), etc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3899
Five User License: US$ 4899
Corporate License: US$ 5899
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the global AI In oncology market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global AI In oncology market?
  • What is the impact of each driver, restraint, and opportunity on the global AI In oncology market?
  • What are the key regional markets?
  • Which countries represent the most attractive AI In oncology market?
  • What is the breakup of the market based on the component?
  • Which is the most attractive component in the AI In oncology market?
  • What is the breakup of the market based on the cancer type?
  • Which is the most attractive cancer type in the AI In oncology market?
  • What is the breakup of the market based on treatment type?
  • Which is the most attractive treatment type in the AI In oncology market?
  • What is the breakup of the market based on application?
  • Which is the most attractive application in the AI In oncology market?
  • What is the competitive structure of the global AI In oncology market?
  • Who are the key players/companies in the global AI In oncology market?

Key Benefits for Stakeholders:

  • IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the AI In oncology market from 2018-2032.
  • The research study provides the latest information on the market drivers, challenges, and opportunities in the global AI In oncology market.
  • The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the AI In oncology industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
AI In Oncology Market Report by Component (Software Solutions, Hardware, Services), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, and Others), Treatment Type (Chemotherapy, Radiotherapy, Immunotherapy, and Others), Application (Cancer Detection, Drug Discovery, Drug Development, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More